Old Web
English
Sign In
Acemap
>
Paper
>
Low-Dose Weekly Decitabine and Venetoclax in TP53-Mutated Myeloid Malignancies
Low-Dose Weekly Decitabine and Venetoclax in TP53-Mutated Myeloid Malignancies
2021
Lauren C Shapiro
Ioannis Mantzaris
Aditi Shastri
R. Alejandro Sica
Lizamarie Bachier-Rodriguez
Noah Kornblum
Kira Gritsman
Eric J. Feldman
Amit Verma
Ira Braunschweig
Yogenthiran Saunthararajah
Mendel Goldfinger
Keywords:
Myeloid
Venetoclax
Cancer research
low dose
Decitabine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]